12:00 AM
 | 
Dec 18, 2000
 |  BC Week In Review  |  Company News  |  Management Tracks

GlycoDesign management update

GlycoDesign Inc. (TSE:GD), Toronto, Ontario
Business: Cancer, Infectious diseases, Autoimmune/Inflammation...

Read the full 30 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >